Lupin recalls over 6 lakh bottles of hypertension drug in U.S.: USFDA
The USFDA reports states that the affected lot is manufactured at Lupin’s Goa-based manufacturing facility. File | Photo Credit: Reuters Drug firm Lupin is recalling over six lakh bottles of a medication indicated for high blood pressure in the U.S. due to deviation from current good manufacturing practices (CGMP), according to the U.S. health regulator….
Read More “Lupin recalls over 6 lakh bottles of hypertension drug in U.S.: USFDA” »

